Search for: "Mylan Pharmaceuticals, Inc"
Results 301 - 320
of 498
Sorted by Relevance
|
Sort by Date
29 Jun 2011, 3:34 am
Sagent Pharmaceuticals, Inc. et al. [read post]
9 Jun 2014, 2:28 pm
He did however dismiss the claims against Mylan Inc., the generic drug maker. [read post]
18 Apr 2012, 1:29 pm
Janssen Pharmaceuticals, Inc., 951 N.E.2d 1238 (Ill. [read post]
23 Dec 2009, 12:40 am
: Proposed amendments to Plant Variety Statute (IP Osgoode) EU: German Federal Supreme Court referral to ECJ concerning embryonic stem cells and the Biotech Directive (EPLAW) EU: Data exclusivity and food claims in Europe - Commission authorises health claim on the effect of water-soluble tomato concentrate on platelet aggregation and grants protection of proprietary data under Regulation (EC) No 1924/2006 (IPKat) France: Pharma trade marks under threat - Senate and National Assembly approve law… [read post]
12 Oct 2010, 8:56 pm
Highlights this week included: Aricept(Donepezil) –US: Declaratory judgment jurisdiction for subsequent Paragraph IV filers: Teva Pharmaceuticals USA, Inc. v. [read post]
19 Mar 2012, 1:31 am
Mylan Pharms., Inc., No. 0247 (Phil. [read post]
28 Dec 2009, 7:57 am
The case is still proceeding against Dey, Inc., Mylan Pharmaceuticals, Inc., Sandoz, Inc. and their parent companies. [read post]
28 Jul 2008, 7:01 pm
Mylan Laboratories, Inc., 520 F.3d 1358, 1364 (Fed. [read post]
26 Sep 2008, 7:23 pm
At the time of the JPMDL hearing in late July 2008 concerning the issue of whether a federal court Digitek MDL was necessary, there were at least 60 lawsuits which had been filed against Actavis Totowa, LLC and Mylan Pharmaceuticals, Inc., as well as numerous other corporate entities related to Acatavis and Mylan. [read post]
9 Aug 2011, 9:50 am
Mylan Pharmaceuticals, Inc., 696 F.Supp.2d 599 (N.D.W. [read post]
16 Jan 2011, 9:48 pm
The manufacturers that filed the appeals case were: Teva Pharmaceutical Industries, Mylan Inc.'s UDL Laboratories and Actavis Inc. [read post]
14 Dec 2010, 6:12 pm
One products liability lawsuit was originally filed by Gladys Mensing, who is suing Teva Pharmaceutical Industries Ltd., Mylan Inc., and Actavis Group. [read post]
16 May 2012, 12:22 pm
Mylan Pharmaceuticals, Inc., ___ F. [read post]
22 Jul 2009, 6:05 am
(PatLit) Levaquin (Levofloxacin) – US: CAFC awards only partial costs where depositions used in multiple cases from different district courts: Ortho-McNeil Pharmaceutical, Inc. v. [read post]
25 Aug 2010, 12:37 am
Watson Pharma, Inc. et al. [read post]
3 Jun 2010, 5:35 am
– In re Ciprofloxacin Antitrust Litigation (PatLit) Circumvent PCV and Porcilis PCV vaccines – US: Wyeth files patent infringement suit against Intervet based on their manufacture of PCV vaccines (Patent Docs) Copegus (Ribavirin) – US: Ascio seeks declaratory judgment of unenforceability, invalidity and non-infringement of Three Rivers’ patent based on ANDA filing (Patent Docs) Entocort (Budesonide) – US: AstraZeneca settles Entocort patent suit with Teva, stipulates… [read post]
28 Jul 2010, 12:06 am
Teva Pharmaceuticals USA, Inc. [read post]
27 Mar 2009, 8:00 am
; no skulduggery involved in pharma enquiry submission switch says EPO (IPKat) (IAM) India: Public sector IP and socially responsible licensing (Spicy IP) India: Pharma lobby wants a probe into delayed orders (Spicy IP) UK: Euro costs in UK litigation: Actavis UK Ltd v Novartis AG (PatLit) US: Two biosimilars bills introduced in the House: HR 1427, the Promoting Innovation and Access to Life Saving Medicine Act; and H.R. 1548, the Pathway to BioSimilars Act (California Biotech Law Blog) (Managing… [read post]
8 Dec 2020, 1:00 pm
[10] Gough, After Nearly 60 Years, Mylan Makes Way for Viatris, Pittsburg Bus. [read post]
16 Dec 2009, 3:39 am
: Ariad Pharmaceuticals, Inc. v. [read post]
